Drugs / p53 gene
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT02435186 | Jun 2015 → Aug 2018 | fallopian tube cancer, malignant epithelial tumor of ovary, primary peritoneal carcinoma | Shenzhen SiBiono GeneTech Co.,Ltd | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | p53 gene | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02435186 ↗ |
| Route | Other | “p53 gene will be given intraperitoneally.” NCT02435186 ↗ |